Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

S-1153: preclinical and preliminary clinical results presented at AIDS congress

Jan. 5, 1999

NIH issues grant to Hughes Institute to further development of anti-HIV contraceptives

Jan. 5, 1999

Oligo- and polyribonucleotides with anti-HIV and anti-HCMV activity

Jan. 4, 1999

New research agreement to advance development of Medical Discoveries' novel AIDS drug

Jan. 4, 1999

New anti-HIV compound progresses in clinical studies at BMS

Jan. 4, 1999

Triangle initiates phase II/III testing of FTC in HIV and HBV infections

Jan. 4, 1999

Anti-HIV, antimalarial agents available for licensing from NIH

Dec. 30, 1998

Shaman achieves favorable phase III results with diarrhea treatment in AIDS patients

Dec. 28, 1998

FDA approves abacavir for treatment of HIV-1 infection

Dec. 21, 1998

NIH seeks licensees for michellamine antiviral agents

Dec. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....